Switch to:
More From Other Websites
3:49 am Jazz Pharma and Nippon Shinyaku enter license agreements for the development and... Mar 30 2017
Jazz Pharmaceuticals and Nippon Shinyaku Enter Into License Agreements for the Development and... Mar 30 2017
Blog Coverage Stemline Announces Completion of Enrollment for the Stage 3 SL-401 Pivotal Trial Mar 24 2017
Actinium Pharmaceuticals (ATNM) Receives New Patents, Boosts Its Portfolio Mar 21 2017
Jazz Sleep Disorder Drug Positive in Phase III Studies Mar 21 2017
Jazz Pharma Isn't Dozing; Stock Breaks Out On Sleep Apnea Trial Mar 20 2017
Nektar, AMD, Esperion, and More: Here’s Why These Five Stocks Are Surging Mar 20 2017
Jazz Pharmaceuticals Announces Positive Results from the Phase 3 TONES 3 and TONES 4 Studies of... Mar 20 2017
Jazz Initiates Phase III Study for Narcolepsy Candidate Mar 16 2017
Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Study Evaluating JZP-258... Mar 15 2017
JAZZ PHARMACEUTICALS PLC Financials Mar 04 2017
Jazz Pharmaceuticals Plc :JAZZ-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017 Mar 02 2017
Jazz Pharma (JAZZ) Q4 Earnings Beat, Sales Miss Estimates Mar 01 2017
Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March Mar 01 2017
Edited Transcript of JAZZ earnings conference call or presentation 28-Feb-17 9:30pm GMT Feb 28 2017
JAZZ PHARMACEUTICALS PLC Files SEC form 10-K, Annual Report Feb 28 2017
Jazz beats 4Q profit forecasts Feb 28 2017
Jazz beats 4Q profit forecasts Feb 28 2017
Jazz Pharmaceuticals PLC Earnings Call scheduled for 4:30 pm ET today Feb 28 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK